Steinberg Martin H
Department of Medicine, Division of Hematology/Oncology, Center of Excellence for Sickle Cell Disease, Center for Regenerative Medicine, Genome Science Institute, Boston University School of Medicine and Boston Medical Center, 72 E. Concord St., Boston, MA 02118, USA.
J Clin Med. 2020 Nov 23;9(11):3782. doi: 10.3390/jcm9113782.
Fetal hemoglobin (HbF) usually consists of 4 to 10% of total hemoglobin in adults of African descent with sickle cell anemia. Rarely, their HbF levels reach more than 30%. High HbF levels are sometimes a result of β-globin gene deletions or point mutations in the promoters of the HbF genes. Collectively, the phenotype caused by these mutations is called hereditary persistence of fetal hemoglobin, or HPFH. The pancellularity of HbF associated with these mutations inhibits sickle hemoglobin polymerization in most sickle erythrocytes so that these patients usually have inconsequential hemolysis and few, if any, vasoocclusive complications. Unusually high HbF can also be associated with variants of the major repressors of the genes, and . Perhaps most often, we lack an explanation for very high HbF levels in sickle cell anemia.
在患有镰状细胞贫血的非洲裔成年人中,胎儿血红蛋白(HbF)通常占总血红蛋白的4%至10%。极少数情况下,他们的HbF水平会超过30%。高HbF水平有时是β珠蛋白基因缺失或HbF基因启动子点突变的结果。这些突变共同导致的表型称为胎儿血红蛋白持续存在,即HPFH。与这些突变相关的HbF全细胞分布抑制了大多数镰状红细胞中镰状血红蛋白的聚合,因此这些患者通常溶血不严重,血管闭塞性并发症很少,甚至没有。异常高的HbF也可能与δ和β基因主要抑制因子的变体有关。也许最常见的情况是,我们无法解释镰状细胞贫血患者HbF水平异常高的原因。